SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-032431
Filing Date
2020-05-27
Accepted
2020-05-27 19:12:48
Documents
1
Period of Report
2020-05-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2115
  Complete submission text file 0001209191-20-032431.txt   3693
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
Qualigen Therapeutics, Inc. (Issuer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1 WALL STREET BURLINGTON MA 01803
Business Address 1 WALL STREET BURLINGTON MA 01803 781-652-7800
SEKISUI DIAGNOSTICS, LLC (Reporting) CIK: 0001812012 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37428 | Film No.: 20916621